Citations (12)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Pawan Kumar, Deepak Sheokand, Annu Grewal, Vandana Saini & Ajit Kumar. (2023) Clinical side-effects based drug repositioning for anti-epileptic activity. Journal of Biomolecular Structure and Dynamics 0:0, pages 1-12.
Read now
Read now
Articles from other publishers (11)
Mohammad Ali, Shahid Ud Din Wani, Mubashir Hussain Masoodi, Nisar Ahmad Khan, H.G. Shivakumar, Riyaz M. Ali Osmani & Khalid Ahmed Khan. (2022) Global Effect of COVID-19 Pandemic on Cancer Patients and its Treatment: A Systematic Review. Clinical Complementary Medicine and Pharmacology 2:4, pages 100041.
Crossref
Crossref
Faqian Bu, Jifa Zhang, Wen Shuai, Jie Liu, Qiu Sun & Liang Ouyang. (2022) Repurposing drugs in autophagy for the treatment of cancer: From bench to bedside. Drug Discovery Today 27:7, pages 1815-1831.
Crossref
Crossref
Lilian Makgoo, Salerwe Mosebi & Zukile Mbita. (2022) Molecular Mechanisms of HIV Protease Inhibitors Against HPV-Associated Cervical Cancer: Restoration of TP53 Tumour Suppressor Activities. Frontiers in Molecular Biosciences 9.
Crossref
Crossref
Mahbuba R. Subeha, Alicia A. Goyeneche, Prisca Bustamante, Michael A. Lisio, Julia V. Burnier & Carlos M. Telleria. (2021) Nelfinavir Induces Cytotoxicity towards High-Grade Serous Ovarian Cancer Cells, Involving Induction of the Unfolded Protein Response, Modulation of Protein Synthesis, DNA Damage, Lysosomal Impairment, and Potentiation of Toxicity Caused by Proteasome Inhibition. Cancers 14:1, pages 99.
Crossref
Crossref
Kelly Féral, Manon Jaud, Céline Philippe, Doriana Di Bella, Stéphane Pyronnet, Kevin Rouault-Pierre, Laurent Mazzolini & Christian Touriol. (2021) ER Stress and Unfolded Protein Response in Leukemia: Friend, Foe, or Both?. Biomolecules 11:2, pages 199.
Crossref
Crossref
Mahbuba R. Subeha & Carlos M. Telleria. (2020) The Anti-Cancer Properties of the HIV Protease Inhibitor Nelfinavir. Cancers 12:11, pages 3437.
Crossref
Crossref
Marta Marcia, Barbara Vania, Giulia Pruccoli, Stefano G. Vallero, Elena Barisone, Carlo Scolfaro & Franca Fagioli. (2020) Acute lymphoblastic leukemia onset in a 3‐year‐old child with COVID‐19. Pediatric Blood & Cancer 67:11.
Crossref
Crossref
Lisa Derosa, Cléa Melenotte, Franck Griscelli, Bertrand Gachot, Aurélien Marabelle, Guido Kroemer & Laurence Zitvogel. (2020) The immuno-oncological challenge of COVID-19. Nature Cancer 1:10, pages 946-964.
Crossref
Crossref
Khanh B. Tran, Christina M. Buchanan & Peter R. Shepherd. (2020) Evolution of Molecular Targets in Melanoma Treatment. Current Pharmaceutical Design 26:4, pages 396-414.
Crossref
Crossref
E. Pontiki, A. Peperidou, I. Fotopoulos & D. Hadjipavlou-Litina. 2020. Cancer-Leading Proteases. Cancer-Leading Proteases
165
182
.
Svetlana Paskas, Emanuela Mazzon, Maria Sofia Basile, Eugenio Cavalli, Yousef Al-Abed, Mingzhu He, Sara Rakocevic, Ferdinando Nicoletti, Sanja Mijatovic & Danijela Maksimovic-Ivanic. (2019) Lopinavir-NO, a nitric oxide-releasing HIV protease inhibitor, suppresses the growth of melanoma cells in vitro and in vivo. Investigational New Drugs 37:5, pages 1014-1028.
Crossref
Crossref